Aandelen in “Fabricage van farmaceutische preparaten”

Aandeel Datum Koers Evolutie
vlag Abbott Laboratories 20/05 103,210 USD
-0,85% 		-0,85%
vlag AbbVie 20/05 164,560 USD
-1,12% 		-1,12%
vlag Abeona Therapeutics Inc 20/05 4,450 USD
+1,14% 		+1,14%
vlag AC Immune SA 20/05 3,160 USD
-0,63% 		-0,63%
vlag Acadia Pharmaceuticals Inc 20/05 15,100 USD
+2,10% 		+2,10%
vlag Acelrx Pharmaceuticals Inc 12/03 1,128 USD
+2,52% 		+2,52%
vlag Acer Therapeutics Inc 20/11 0,660 USD
-17,95% 		-17,95%
vlag Aclaris Therapeutics Inc 20/05 1,190 USD
0,00% 		0,00%
vlag Actinium Pharmaceuticals Inc 20/05 9,690 USD
-1,12% 		-1,12%
vlag Adamis Pharmaceuticals Corp 9/11 0,490 USD
-2,97% 		-2,97%
vlag Adc Therapeutics SA 20/05 4,110 USD
+0,24% 		+0,24%
vlag Addex Therapeutics Ltd 20/05 8,800 USD
+0,11% 		+0,11%
vlag Addex Therapeutics Ltd 17/05 0,068 CHF
+5,59% 		+5,59%
vlag Adial Pharmaceuticals Inc 20/05 1,500 USD
-3,25% 		-3,25%
vlag Aditx Therapeutics Inc 20/05 2,090 USD
+3,98% 		+3,98%
vlag Advaxis, Inc. 20/05 0,300 USD
+36,36% 		+36,36%
vlag Aeglea BioTherapeutics Inc 29/01 27,660 USD
+0,58% 		+0,58%
vlag Affimed N.V. 20/05 5,160 USD
-1,71% 		-1,71%
vlag Agile Therapeutics Inc 20/05 0,374 USD
-0,98% 		-0,98%
vlag Agios Pharmaceuticals Inc 20/05 33,190 USD
-3,35% 		-3,35%
vlag Aileron Therapeutics Inc 20/05 3,690 USD
-2,12% 		-2,12%
vlag Akebia Therapeutics Inc. 20/05 1,150 USD
0,00% 		0,00%
vlag Akero Therapeutics Inc 20/05 20,140 USD
+1,10% 		+1,10%
vlag Alaunos Therapeutics Inc 20/05 1,110 USD
-4,31% 		-4,31%
vlag Albireo Pharma Inc 2/03 44,150 USD
-0,23% 		-0,23%
vlag Aldeyra Therapeutics Inc 20/05 4,030 USD
+2,03% 		+2,03%
vlag Alimera Sciences Inc. 20/05 3,160 USD
-1,25% 		-1,25%
vlag Alkermes plc 20/05 24,380 USD
+0,95% 		+0,95%
vlag Alnylam Pharmaceuticals Inc 20/05 150,240 USD
+0,56% 		+0,56%
vlag Alpine Immune Sciences Inc 17/05 64,970 USD
+0,02% 		+0,02%
vlag Altimmune Inc 20/05 8,040 USD
+0,37% 		+0,37%
vlag Amarin Corp 20/05 0,880 USD
+1,14% 		+1,14%
vlag Amicus Therapeutics Inc 20/05 9,750 USD
+1,88% 		+1,88%
vlag Amneal Pharmaceuticals Inc 20/05 6,730 USD
-1,32% 		-1,32%
vlag Amneal Pharmaceuticals Inc - Class A 20/05 6,730 USD
-1,32% 		-1,32%
vlag Amphastar Pharmaceuticals Inc 20/05 43,070 USD
-0,94% 		-0,94%
vlag Ampio Pharmaceuticals Inc 20/05 0,220 USD
-8,94% 		-8,94%
vlag AnaptysBio Inc 20/05 25,010 USD
-0,24% 		-0,24%
vlag Anavex Life Sciences Corporation 20/05 4,430 USD
-2,64% 		-2,64%
vlag Annexon Inc 20/05 4,680 USD
+8,08% 		+8,08%
vlag Annovis Bio Inc 20/05 8,750 USD
+5,29% 		+5,29%
vlag Apellis Pharmaceuticals Inc 20/05 43,220 USD
+4,62% 		+4,62%
vlag Applied Molecular Transport Inc 26/12 0,263 USD
-14,30% 		-14,30%
vlag Aprea Therapeutics Inc 20/05 5,281 USD
+0,21% 		+0,21%
vlag Aptevo Therapeutics Inc 20/05 0,744 USD
-7,00% 		-7,00%
vlag Aptinyx Inc 29/12 0,096 USD
+3,17% 		+3,17%
vlag Aravive Inc 26/01 0,040 USD
-13,39% 		-13,39%
vlag Arbutus Biopharma Corp 20/05 3,070 USD
+3,02% 		+3,02%
vlag ARCA biopharma Inc 20/05 3,260 USD
-2,10% 		-2,10%
vlag Arcturus Therapeutics Holdings Inc 20/05 30,500 USD
+2,42% 		+2,42%
vlag Arcus Biosciences Inc 20/05 16,780 USD
-0,71% 		-0,71%
vlag Arcutis Biotherapeutics Inc 20/05 9,350 USD
+1,63% 		+1,63%
vlag Ardelyx Inc 20/05 7,930 USD
+1,54% 		+1,54%
vlag Arrowhead Pharmaceuticals Inc. 20/05 24,820 USD
+0,20% 		+0,20%
vlag Ascendis Pharma A/S 20/05 121,070 USD
-0,04% 		-0,04%
vlag ASLAN Pharmaceuticals Ltd 20/05 0,499 USD
+12,46% 		+12,46%
vlag Assembly Biosciences Inc 20/05 14,960 USD
+2,96% 		+2,96%
vlag AstraZeneca 20/05 12.096,000 GBX
-0,12% 		-0,12%
vlag AstraZeneca 20/05 77,110 USD
+0,27% 		+0,27%
vlag Athenex Inc 26/07 0,006 USD
+103,33% 		+103,33%
vlag Athersys Inc 11/03 0,007 USD
-14,47% 		-14,47%
vlag Atreca Inc 20/05 0,092 USD
0,00% 		0,00%
vlag Aurinia Pharmaceuticals Inc 20/05 5,780 USD
+0,35% 		+0,35%
vlag Avenue Therapeutics Inc 20/05 3,810 USD
+2,14% 		+2,14%
vlag Avid Bioservices Inc 20/05 9,280 USD
+1,75% 		+1,75%
vlag Avidity Biosciences Inc 20/05 29,240 USD
-0,88% 		-0,88%
vlag Avricore Health Inc. 17/05 0,155 CAD
-3,12% 		-3,12%
vlag Axsome Therapeutics Inc 20/05 77,580 USD
+1,36% 		+1,36%
vlag Aytu BioScience Inc 20/05 3,080 USD
+4,76% 		+4,76%

Nieuws over “Fabricage van farmaceutische preparaten”

20/05 · Sanofi: Information concerning the total number of voting rights and shares - April 2024 · Persbericht

20/05 · Sanofi: Information concerning the total number of voting rights and shares - April 2024 · Persbericht

20/05 · Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE® (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session · Persbericht

20/05 · Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM · Persbericht

20/05 · Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and Arcturus Therapeutics' COVID-19 Vaccine · Persbericht

20/05 · Soligenix Encourages Stockholders to Vote Prior to Annual Meeting · Persbericht

20/05 · PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation · Persbericht

17/05 · BioLineRx Announces Receipt of Nasdaq Minimum Bid Price Notification · Persbericht

17/05 · AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease Week® · Persbericht

17/05 · Seelos Therapeutics Announces Pricing of $1.1 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules · Persbericht

17/05 · AKRO Investors: Reminder - Important Deadline in Securities Fraud Class Action Lawsuit Akero Therapeutics, Inc. · Persbericht

16/05 · Galapagos creates new subscription right plans · Persbericht

16/05 · Galapagos creëert nieuwe inschrijvingsrechtenplannen · Persbericht

16/05 · Moleculin Abstract Accepted for Poster Presentation at the European Hematology Association (EHA) 2024 Hybrid Congress · Persbericht

16/05 · Regulus Therapeutics Announces Promotion of Rekha Garg, M.D., M.S., to Chief Medical Officer · Persbericht

16/05 · Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis · Persbericht

16/05 · Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice · Persbericht

16/05 · Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-Monocyte · Persbericht

16/05 · Ionis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome · Persbericht

16/05 · With Once-a-Week Dosing, Insulin Efsitora Alfa Delivers A1C Reduction and Safety Profile Consistent with Daily Insulin · Persbericht

15/05 · Galapagos gaat kankertherapie produceren in Amerikaanse bloedcentra · Tijd.be (€)

Het beursgenoteerde Mechelse biotechbedrijf Galapagos gaat samenwerken met Blood Centers of America, het grootste Amerikaanse bloedvoorzieningsnetwerk, om er lokaal zijn gepersonaliseerde kankerbehand...

Mijn selecties